These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34254805)

  • 21. Translocator protein: pharmacology and steroidogenesis.
    Midzak A; Zirkin B; Papadopoulos V
    Biochem Soc Trans; 2015 Aug; 43(4):572-8. PubMed ID: 26551695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Translocator Protein 18 kDa (TSPO) and Its Role in Mitochondrial Biology and Psychiatric Disorders.
    Milenkovic VM; Rupprecht R; Wetzel CH
    Mini Rev Med Chem; 2015; 15(5):366-72. PubMed ID: 25807946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translocator protein as a promising target for novel anxiolytics.
    Costa B; Da Pozzo E; Martini C
    Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolving understanding of translocator protein 18 kDa (TSPO).
    Li F; Liu J; Garavito RM; Ferguson-Miller S
    Pharmacol Res; 2015 Sep; 99():404-9. PubMed ID: 25882248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocator protein (18 kDa) as a pharmacological target in adipocytes to regulate glucose homeostasis.
    Li J; Papadopoulos V
    Biochem Pharmacol; 2015 Sep; 97(1):99-110. PubMed ID: 26123521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting mitochondrial energy metabolism with TSPO ligands.
    Gut P
    Biochem Soc Trans; 2015 Aug; 43(4):537-42. PubMed ID: 26551690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis.
    Lejri I; Grimm A; Hallé F; Abarghaz M; Klein C; Maitre M; Schmitt M; Bourguignon JJ; Mensah-Nyagan AG; Bihel F; Eckert A
    J Alzheimers Dis; 2019; 72(4):1045-1058. PubMed ID: 31256132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular cholesterol changes induced by translocator protein (18 kDa) TSPO/PBR ligands.
    Falchi AM; Battetta B; Sanna F; Piludu M; Sogos V; Serra M; Melis M; Putzolu M; Diaz G
    Neuropharmacology; 2007 Aug; 53(2):318-29. PubMed ID: 17631921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma.
    Papadopoulos V; Lecanu L
    Exp Neurol; 2009 Sep; 219(1):53-7. PubMed ID: 19409385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there any correlation between binding and functional effects at the translocator protein (TSPO) (18 kDa)?
    Scarf AM; Auman KM; Kassiou M
    Curr Mol Med; 2012 May; 12(4):387-97. PubMed ID: 22348609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
    Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies.
    Grimm A; Lejri I; Hallé F; Schmitt M; Götz J; Bihel F; Eckert A
    J Neuroendocrinol; 2020 Jan; 32(1):e12796. PubMed ID: 31536662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells.
    Zeno S; Zaaroor M; Leschiner S; Veenman L; Gavish M
    Biochemistry; 2009 Jun; 48(21):4652-61. PubMed ID: 19358520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translocator protein (TSPO) in breast cancer.
    Mukherjee S; Das SK
    Curr Mol Med; 2012 May; 12(4):443-57. PubMed ID: 22348612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.
    Rupprecht R; Papadopoulos V; Rammes G; Baghai TC; Fan J; Akula N; Groyer G; Adams D; Schumacher M
    Nat Rev Drug Discov; 2010 Dec; 9(12):971-88. PubMed ID: 21119734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
    Nack A; Brendel M; Nedelcu J; Daerr M; Nyamoya S; Beyer C; Focke C; Deussing M; Hoornaert C; Ponsaerts P; Schmitz C; Bartenstein P; Rominger A; Kipp M
    Cells; 2019 Jan; 8(2):. PubMed ID: 30696113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSPO targeted dendrimer imaging agent: synthesis, characterization, and cellular internalization.
    Samuelson LE; Dukes MJ; Hunt CR; Casey JD; Bornhop DJ
    Bioconjug Chem; 2009 Nov; 20(11):2082-9. PubMed ID: 19863077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in potential anxiolytic agents targeting GABAA/BzR complex or the translocator protein (18kDa) (TSPO).
    Nothdurfter C; Rupprecht R; Rammes G
    Curr Top Med Chem; 2012; 12(4):360-70. PubMed ID: 22204486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational studies on translocator protein (TSPO) and its ligands.
    Ortore G; Tuccinardi T; Martinelli A
    Curr Top Med Chem; 2012; 12(4):352-9. PubMed ID: 22204485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases.
    Hector M; Langmann T; Wolf A
    Prog Retin Eye Res; 2024 May; 100():101249. PubMed ID: 38430990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.